(Q78148165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

B Masereel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Damas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Fontaine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

M Lembege

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

F Lacan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A Nuhrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Delarge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J M Dogne

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

695-701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Synthesis and structure of the platelet aggregation factor thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

THE AGGREGATION OF BLOOD PLATELETS

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Prostanoid-induced contractions are blocked by sulfonylureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Torasemide. A review of its pharmacological properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Na+,2Cl-,K+ cotransport system as a marker of antihypertensive activity of new torasemide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

A sulphonylthiourea (BM 20) related to torasemide: a new loop diuretic with relative potassium-sparing properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Clinical implications of prostaglandin and thromboxane A2 formation (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Clinical implications of prostaglandin and thromboxane A2 formation (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772998

21 January 2018

Identifiers

DOI

10.1211/0022357991772998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10454046%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference